Stock screener

BNGO

Conviction 31IndustrialsScan · Mon, Aug 10, 2026
BNGO$1.17+0.86%
ResistanceSupportVol 14
63 bars
Vol MA14 132.05K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Bionano Genomics, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.bionano.com
Price1.17
Change+0.86%
Gap-1.29%
Rel volume2.86×
Avg volume112.5K
Avg $ vol125.44K
SMA 201.12
SMA 501.15
SMA 2001.33
Price vs 50+1.65%
Price vs 200-11.92%
MA stackmixed
50/200 cross
Supertrendup · 1.06
RSI (14)57
MACD hist0.01
MACD crossbull · 2d
Stoch %K / %D89 / 85
ADX (14)15
+DI / −DI25 / 20
RSI divergence
MACD divergence
ATR %+3.88%
ADR %3.54%
52w high4.92
52w low1.06
From 52w high-76.22%
Above 52w low+10.38%
New 52w highNo
SqueezeOff
Bollinger width12.87%
%B0.86
Donchian pos85.00%
Donchian high1.20
Donchian low1.00
AVWAP (52w high)1.65
vs AVWAP high-29.26%
AVWAP (52w low)1.11
vs AVWAP low+5.10%
OBV trendUp
Chaikin MF (20)-0.11
Today vs 20d2.86×
Avg vol (14d)132.05K
Avg vol (20d)112.5K
Avg $ vol (20d)125.44K
Market cap13.78M
RS 3m (vs SPY)-18.48%
RS 6m (vs SPY)-11.00%
RS line new highNo
Trend template1/8
Technical rank41.5
1 week+4.93%
1 month-2.50%
3 months-9.30%
6 months+1.74%
1 year-60.07%
YTD-26.42%
P/E-0.52
P/B0.44
P/S0.48
P/FCF-0.84
EPS-4.85
Div yield
ROE-83.51%
ROA-55.46%
Debt/Eq0.00
Current2.48
EV/EBITDA-0.42
Gross margin
Net margin-92.59%
Rev growth-7.37%
EPS growth76.44%
Price target
Target upside
Analyst rating
Institutional
Ent. value10.05M
Revenue8.17M
Net income-7.42M
Gross profit
Free cash flow-16.34M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out11.47M
Employees97
ListedWed, Aug 1, 2018
Free float11.08M
Float %99.9%
Short interest1.09M
Days to cover8.6d
Short volume30.0%
Squeeze score60 / 100
Next earningsMon, Aug 10, 2026 · after (0d)
EPS forecast−$0.70 · 1 est
Last EPS vs est
Last surprise
Setup gradeD
Conviction31 / 100
Pattern quality
Tech rank41.5 / 100
Group rank68 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance1.21
Support1.04
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BNGO

All disclosures →
No recent disclosed trades by Congress in BNGO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BNGO · 6 buys · 4 sells

InsiderSideShares
Adamchak Mark
Principal Accounting Officer · Stock Option (Right to Buy) · 2026-08-03
Grant5K
OLDAKOWSKI MARK
Chief Operating Officer · Stock Option (Right to Buy) · 2026-08-03
Grant15K
Dixon Jonathan V.
General Counsel · Stock Option (Right to Buy) · 2026-08-03
Grant15K
Hastie Alex Reid
Chief Scientific Officer · Stock Option (Right to Buy) · 2026-08-03
Grant54K
Adamchak Mark
Principal Accounting Officer · Common Stock · 2026-06-03
Tax7
Dixon Jonathan V.
GENERAL COUNSEL · Common Stock · 2026-06-03
Tax24
Chaubey Alka
CHIEF MEDICAL OFFICER · Common Stock · 2026-06-03
Tax24
OLDAKOWSKI MARK
CHIEF OPERATING OFFICER · Common Stock · 2026-06-03
Tax27
Linney Yvonne
Director · Stock Option (Right to Buy) · 2026-05-14
Grant9.15K
BARKER DAVID L
Director · Stock Option (Right to Buy) · 2026-05-14
Grant9.15K

SEC filings

EDGAR filings in BNGO · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.